© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Researchers believe their greater understanding of leukemia stem cells will lead to more treatment options for people with the blood cancer.
Researchers called the results of treatment using Venclexta (venetoclax) and Vidaza (azacitidine) “remarkably impressive.”
The study used two FDA-approved drugs to the pre-leukemic cells while leaving healthy stem cells alone.
The researchers hope to develop a clinical trial to combine arsenic with the standard therapy for women with triple-negative breast cancer.
Recent work increasingly shows that a tumor’s cells evolve in response to treatment, often in ways that lead to loss of response.
Similarities between these two mammals may boost human cancer research.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
